Skip to main content
OpenTrials
Completed

NCT Number: NCT05215223

Effect of Whole Body Vibration on Insulin Resistance in Females With Polycystic Ovarian Syndrome

The purpose of this study is to investigate the effect of whole body vibration on insulin resistance in females with polycystic ovarian syndrome

Completed

Looking for future studies?

Notify Me

Key information

About this study

polycystic ovarian syndrome is a complex endocrine condition characterized by metabolic abnormalities such as insulin resistance, excess weight or obesity, diabetes, and an increased risk of cardiovascular disease.Despite previous studies reported that physical exercise improves insulin resistance in females with polycystic ovarian syndrome, there is no study yet investigate the effect of whole body vibration on insulin resistance

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Females with polycystic ovarian syndrome.
  • Their ages will range from 20 to 35 years.

Exclusion criteria

  • 1-Smoking. 2-History of chronic disease.

Treatment and study plan

Whole Body Vibration

Device

the patients will stand on whole body vibration device with maintaining squatting position while keeping their trunk extended. The first training session will be consisted of three sets of 1 min and will be separated by a 1-min of standing rest. intensity will 1 mm. Then one set will be added every session

Treadmill

Device

Females will be asked to perform moderate intensity aerobic exercise for 45 minutes for 3 times per week for 8 weeks

Primary outcomes

  1. Homeostasis Model Assessment (HOMA-IR)

    Time frame: eight weeks

    Estimate insulin resistance (IR), it will be calculated according to the formula: fasting insulin (microU/L) x fasting glucose (nmol/L)/22.5.

Secondary outcomes

  1. Waist circumference

    Time frame: eight weeks

    by a tape measurement around the waist

  2. waist hip ratio

    Time frame: eight weeks

    The formula = waist circumference / hip circumference.

  3. LH/FSH ratio

    Time frame: Eight weeks

    To assess the severity of PCOS

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Acronym: WBV

Important dates

Study start
2022
Primary completion
2023
Study completion
2023
First posted
Jan 31, 2022
Registry last updated
Oct 17, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.